Evolution of the SURvival of Patients With SEzary Syndrome (SS) Over the 1998-2020 Period and Its Association With the Early Use of Therapeutic Monoclonal Antibodies

NCT05206045 · clinicaltrials.gov ↗

UNKNOWN

Status

700

Enrollment

OTHER

Sponsor class

Conditions

Sezary Syndrome
Cutaneous T Lymphoma

Interventions

OTHER: Standard of care

Sponsor

Assistance Publique - Hôpitaux de Paris